Article info

Download PDFPDF

Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectable

Authors

  • Elena Ongaro Unit of Medical Oncology 2, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy Department of Oncology, Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy PubMed articlesGoogle scholar articles
  • Chiara Cremolini Unit of Medical Oncology 2, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy PubMed articlesGoogle scholar articles
  • Daniele Rossini Unit of Medical Oncology 2, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy PubMed articlesGoogle scholar articles
  • Francesca Corti Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy PubMed articlesGoogle scholar articles
  • Filippo Pagani Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy PubMed articlesGoogle scholar articles
  • Luca Morelli General Surgery Unit, Department of Translational Research and New Technologies in Medicine and Surgery, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy PubMed articlesGoogle scholar articles
  • Lucio Urbani Department of General Surgery, Liver Metastasis Parenchyma Sparing Surgery Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy PubMed articlesGoogle scholar articles
  • Gianluca Masi Unit of Medical Oncology 2, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy PubMed articlesGoogle scholar articles
  • Carlo Sposito Department of Gastrointestinal and Hepatobilio-Pancreatic Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy PubMed articlesGoogle scholar articles
  • Beatrice Filippi Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy PubMed articlesGoogle scholar articles
  • Beatrice Borelli Unit of Medical Oncology 2, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy PubMed articlesGoogle scholar articles
  • Gemma Zucchelli Unit of Medical Oncology 2, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy PubMed articlesGoogle scholar articles
  • Roberto Moretto Unit of Medical Oncology 2, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy PubMed articlesGoogle scholar articles
  • Alessandra Boccaccino Unit of Medical Oncology 2, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy PubMed articlesGoogle scholar articles
  • Leonardo Solaini Department of Medical and Surgical Sciences, DIMEC, Alma Mater Studiorum, University of Bologna, Bologna, Italy PubMed articlesGoogle scholar articles
  • Filippo de Braud Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy Department of Oncology and Hemato-oncology, Universityof Milan, Milan, Italy PubMed articlesGoogle scholar articles
  • Vincenzo Mazzaferro Department of Gastrointestinal and Hepatobilio-Pancreatic Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy PubMed articlesGoogle scholar articles
  • Alfredo Falcone Unit of Medical Oncology 2, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy PubMed articlesGoogle scholar articles
  • Alessandro Cucchetti Department of Medical and Surgical Sciences, DIMEC, Alma Mater Studiorum, University of Bologna, Bologna, Italy PubMed articlesGoogle scholar articles
  • Filippo Pietrantonio Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy Department of Oncology and Hemato-oncology, Universityof Milan, Milan, Italy PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Chiara Cremolini; chiaracremolini{at}gmail.com
View Full Text

Citation

Ongaro E, Cremolini C, Rossini D, et al
Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectable

Publication history

  • Received January 19, 2019
  • Revised February 19, 2019
  • Accepted February 21, 2019
  • First published May 9, 2019.
Online issue publication 
May 09, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.